Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Mol Genet Metab ; 102(1): 49-56, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20934363

RESUMO

Mucopolysaccharidoses (MPSs) are complex storage disorders caused by specific lysosomal enzyme deficiencies, resulting in the accumulation of glycosaminoglycans (GAGs) in urine, plasma, as well as in various tissues. We devised and validated a straightforward, but accurate and precise tandem mass spectrometry methodology coupled to high performance liquid chromatography (LC-MS/MS) for the quantification of GAGs in urine. The method is applicable to the investigation of patients with MPS I, II, and VI, by quantifying dermatan sulfate (DS) and heparan sulfate (HS) in urine. We analyzed urine samples from 28 MPS patients, aged 1 to 42 years, and 55 control subjects (41 days to 18 years old). Levels of DS and HS in urine from healthy controls of all ages were below the limit of quantification. The levels of DS and HS in urine from 6 treated patients with MPS I were lower than in 6 untreated patients in DS (0.7-45 vs 9.3-177 mg/mmol creat) and HS (0-123 mg/mmol creatinine vs 38-418 mg/mmol creatinine); similar results were obtained for 9 patients with MPS II and 7 patients with MPS VI. Analyses were performed on as little as 250 µL of urine. Methanolysis took 75 min per sample; the total analysis run time for each LC-MS/MS injection was 8 min. Results indicate that the method is applicable to a wide variety of situations in which high accuracy and precision are required, including the evaluation of the effectiveness of existing and emerging treatments.


Assuntos
Glicosaminoglicanos/urina , Mucopolissacaridose II/urina , Mucopolissacaridose I/urina , Mucopolissacaridose VI/urina , Adolescente , Adulto , Biomarcadores/urina , Estudos de Casos e Controles , Criança , Pré-Escolar , Cromatografia Líquida , Creatinina/urina , Dermatan Sulfato/urina , Terapia de Reposição de Enzimas , Feminino , Heparitina Sulfato/urina , Humanos , Lactente , Masculino , Mucopolissacaridose I/diagnóstico , Mucopolissacaridose II/diagnóstico , Mucopolissacaridose VI/diagnóstico , Valores de Referência , Espectrometria de Massas em Tandem , Adulto Jovem
2.
Bioorg Med Chem Lett ; 18(16): 4731-5, 2008 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-18640834

RESUMO

A new method for solid phase parallel synthesis of chemically and conformationally diverse macrocyclic peptidomimetics is reported. A key feature of the method is access to broad chemical and conformational diversity. Synthesis and mechanistic studies on the macrocyclization step are reported.


Assuntos
Química Farmacêutica/métodos , Peptídeos Cíclicos/química , Técnicas de Química Combinatória , Dimerização , Dipeptídeos , Modelos Químicos , Modelos Moleculares , Conformação Molecular , Mimetismo Molecular , Estrutura Molecular , Peptídeos/química , Prata/química , Estereoisomerismo , Relação Estrutura-Atividade
3.
JIMD Rep ; 39: 89-96, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28766179

RESUMO

Glutaric aciduria type 3 (GA3) is associated with decreased conversion of free glutaric acid to glutaryl-coA, reflecting deficiency of succinate-hydroxymethylglutarate coA-transferase, caused by variants in the SUGCT (C7orf10) gene. GA3 remains less well known, characterised and understood than glutaric aciduria types 1 and 2. It is generally considered a likely "non-disease," but this is based on limited supporting information, with only nine individuals with GA3 described in the literature. Clinicians encountering a patient with GA3 therefore still face a dilemma of whether or not this should be dismissed as irrelevant.We have identified three unrelated Canadian patients with GA3. Two came to clinical attention because of symptoms, while the third was identified by a population urine-based newborn screening programme and has so far remained asymptomatic. We describe the clinical histories, biochemical characterisation and genotypes of these individuals. Examination of allele frequencies underlines the fact that GA3 is underdiagnosed. While one probable factor is that some GA3 patients remain asymptomatic, we highlight other plausible reasons whereby this diagnosis might be overlooked.Gastrointestinal disturbances were previously reported in some GA3 patients. In one of our patients, severe episodes of cyclic vomiting were the major problem. A trial of antibiotic treatment, to minimise bacterial GA production, was followed by significant clinical improvement.At present, there is insufficient evidence to define any specific clinical phenotype as attributable to GA3. However, we consider that it would be premature to assume that this condition is completely benign in all individuals at all times.

4.
Nat Med ; 22(4): 439-45, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26974308

RESUMO

Tissues with high metabolic rates often use lipids, as well as glucose, for energy, conferring a survival advantage during feast and famine. Current dogma suggests that high-energy-consuming photoreceptors depend on glucose. Here we show that the retina also uses fatty acid ß-oxidation for energy. Moreover, we identify a lipid sensor, free fatty acid receptor 1 (Ffar1), that curbs glucose uptake when fatty acids are available. Very-low-density lipoprotein receptor (Vldlr), which is present in photoreceptors and is expressed in other tissues with a high metabolic rate, facilitates the uptake of triglyceride-derived fatty acid. In the retinas of Vldlr(-/-) mice with low fatty acid uptake but high circulating lipid levels, we found that Ffar1 suppresses expression of the glucose transporter Glut1. Impaired glucose entry into photoreceptors results in a dual (lipid and glucose) fuel shortage and a reduction in the levels of the Krebs cycle intermediate α-ketoglutarate (α-KG). Low α-KG levels promotes stabilization of hypoxia-induced factor 1a (Hif1a) and secretion of vascular endothelial growth factor A (Vegfa) by starved Vldlr(-/-) photoreceptors, leading to neovascularization. The aberrant vessels in the Vldlr(-/-) retinas, which invade normally avascular photoreceptors, are reminiscent of the vascular defects in retinal angiomatous proliferation, a subset of neovascular age-related macular degeneration (AMD), which is associated with high vitreous VEGFA levels in humans. Dysregulated lipid and glucose photoreceptor energy metabolism may therefore be a driving force in macular telangiectasia, neovascular AMD and other retinal diseases.


Assuntos
Ácidos Graxos/metabolismo , Degeneração Macular/metabolismo , Células Fotorreceptoras/metabolismo , Receptores Acoplados a Proteínas G/genética , Receptores de LDL/metabolismo , Retina/metabolismo , Animais , Regulação da Expressão Gênica , Glucose/metabolismo , Humanos , Ácidos Cetoglutáricos/metabolismo , Metabolismo dos Lipídeos/genética , Degeneração Macular/genética , Degeneração Macular/patologia , Camundongos , Oxirredução , Células Fotorreceptoras/patologia , Receptores Acoplados a Proteínas G/biossíntese , Receptores de LDL/genética , Retina/patologia , Neovascularização Retiniana/genética , Neovascularização Retiniana/metabolismo , Neovascularização Retiniana/patologia , Fator A de Crescimento do Endotélio Vascular/genética , Fator A de Crescimento do Endotélio Vascular/metabolismo
5.
J Med Chem ; 54(24): 8305-20, 2011 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-22106937

RESUMO

High-throughput screening of Tranzyme Pharma's proprietary macrocycle library using the aequorin Ca2+-bioluminescence assay against the human ghrelin receptor (GRLN) led to the discovery of novel agonists against this G-protein coupled receptor. Early hits such as 1 (Ki=86 nM, EC50=134 nM) though potent in vitro displayed poor pharmacokinetic properties that required optimization. While such macrocycles are not fully rule-of-five compliant, principally due to their molecular weight and clogP, optimization of their pharmacokinetic properties proved feasible largely through conformational rigidification. Extensive SAR led to the identification of 2 (Ki=16 nM, EC50=29 nM), also known as ulimorelin or TZP-101, which has progressed to phase III human clinical trials for the treatment of postoperative ileus. X-ray structure and detailed NMR studies indicated a rigid peptidomimetic portion in 2 that is best defined as a nonideal type-I' ß-turn. Compound 2 is 24% orally bioavailable in both rats and monkeys. Despite its potency, in vitro and in gastric emptying studies, 2 did not induce growth hormone (GH) release in rats, thus demarcating the GH versus GI pharmacology of GRLN.


Assuntos
Compostos Macrocíclicos/síntese química , Peptidomiméticos/síntese química , Receptores de Grelina/agonistas , Administração Oral , Animais , Disponibilidade Biológica , Células CACO-2 , Permeabilidade da Membrana Celular , Cristalografia por Raios X , Hormônio do Crescimento/metabolismo , Humanos , Técnicas In Vitro , Macaca fascicularis , Compostos Macrocíclicos/farmacocinética , Compostos Macrocíclicos/farmacologia , Espectroscopia de Ressonância Magnética , Masculino , Microssomos Hepáticos/metabolismo , Oligopeptídeos/síntese química , Oligopeptídeos/farmacocinética , Oligopeptídeos/farmacologia , Peptidomiméticos/farmacocinética , Peptidomiméticos/farmacologia , Conformação Proteica , Ratos , Ratos Sprague-Dawley , Estereoisomerismo , Relação Estrutura-Atividade
7.
PLoS One ; 5(6): e10956, 2010 Jun 04.
Artigo em Inglês | MEDLINE | ID: mdl-20532041

RESUMO

BACKGROUND: It has been proposed that abnormal postprandial plasma nonesterified fatty acid (NEFA) metabolism may participate in the development of tissue lipotoxicity and type 2 diabetes (T2D). We previously found that non-diabetic offspring of two parents with T2D display increased plasma NEFA appearance and oxidation rates during intravenous administration of a fat emulsion. However, it is currently unknown whether plasma NEFA appearance and oxidation are abnormal during the postprandial state in these subjects at high-risk of developing T2D. METHODOLOGY: Palmitate appearance and oxidation rates and glycerol appearance rate were determined in eleven healthy offspring of two parents with T2D (positive family history, FH+), 13 healthy subjects without first-degree relatives with T2D (FH-) and 12 subjects with T2D at fasting, during normoglycemic hyperinsulinemic clamp and during continuous oral intake of a standard liquid meal to achieve steady postprandial NEFA and triacylglycerols (TG) without and with insulin infusion to maintain similar glycemia in all three groups. PRINCIPAL FINDINGS: Plasma palmitate appearance and oxidation were higher at fasting and during the clamp conditions in the T2D group (all P<0.05). In the postprandial state, palmitate appearance, oxidative and non oxidative rates were all elevated in T2D (all P<0.05) but not in FH+. Both T2D and FH+ displayed elevated postprandial TG vs. FH- (P<0.001). Acute correction of hyperglycemia during the postprandial state did not affect these group differences. Increased waist circumference and BMI were positively associated with elevated postprandial plasma palmitate appearance and oxidation. CONCLUSIONS/SIGNIFICANCE: Postprandial plasma NEFA intolerance observed in subjects with T2D is not fully established in non-diabetic offspring of both parents with T2D, despite the presence of increased postprandial plasma TG in the later. Elevated postprandial plasma NEFA appearance and oxidation in T2D is observed despite acute correction of the exaggerated glycemic excursion in this group.


Assuntos
Diabetes Mellitus Tipo 2/sangue , Família , Ácidos Graxos não Esterificados/sangue , Período Pós-Prandial , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oxirredução
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA